QSAM Biosciences Preço/Valor Contábil
Qual é o Preço/Valor Contábil de QSAM Biosciences?
O Preço/Valor Contábil de QSAM Biosciences, Inc. é -747.12
Qual é a definição de Preço/Valor Contábil?
A razão entre cotação e valor contabilístico representa a razão entre o valor das ações de uma empresa e o valor contábil por ação.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Preço/Valor Contábil de empresas na Setor Health Care em OTC em comparação com QSAM Biosciences
O que QSAM Biosciences faz?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Empresas com preço/valor contábil semelhantes a QSAM Biosciences
- Motorola Solutions tem Preço/Valor Contábil de -1,071.50
- AL tem Preço/Valor Contábil de -1,056.48
- Live Nation Entertainment Inc tem Preço/Valor Contábil de -984.08
- Baylin Technologies tem Preço/Valor Contábil de -914.04
- Maxeon Solar Technologies tem Preço/Valor Contábil de -830.21
- KNK tem Preço/Valor Contábil de -808.36
- QSAM Biosciences tem Preço/Valor Contábil de -747.12
- BlueBird Battery Metals tem Preço/Valor Contábil de -695.44
- Jinzisheng tem Preço/Valor Contábil de -690.00
- Match tem Preço/Valor Contábil de -636.68
- AMBG tem Preço/Valor Contábil de -620.00
- ContourGlobal Plc tem Preço/Valor Contábil de -532.00
- Clear Leisure plc tem Preço/Valor Contábil de -510.00